Brege Laura
Director
3 companies
Insider Signal Score
62
GoodTrades Analyzed
7
12M Win Rate
80.0%
Avg 3M Return
+3.7%
Avg 12M Return
+25.1%
Brege Laura is a Director at Mirum Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $4.5M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Director | Sale+OE | 17,000 | $74.40 | $1,264,868.43 | -34.1% | -14.9% | - | |
| Jun 4, 2025 | ACAD Acadia Pharmaceuticals Inc | Director | Sell | 14,446 | $21.78 | $314,633.88 | -48.9% | +18.0% | - | |
| Aug 16, 2024 | PCRX Pacira Biosciences, Inc. | Director | Buy | 1,000 | $12.81 | $12,810.00 | +6.0% | +26.5% | +91.5% | |
| Jun 12, 2023 | ACAD Acadia Pharmaceuticals Inc | Director | Sell | 4,500 | $24.87 | $111,906.00 | -25.0% | +10.2% | -38.9% | |
| Jun 5, 2023 | PCRX Pacira Biosciences, Inc. | Director | Sell | 600 | $38.74 | $23,244.00 | -5.9% | -9.8% | -20.8% | |
| Apr 3, 2023 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 7,000 | $40.72 | $285,040.00 | -40.8% | -3.1% | -31.1% | |
| Jan 12, 2023 | ACAD Acadia Pharmaceuticals Inc | Director | Sale+OE | 12,500 | $18.25 | $228,125.00 | -100% | 0.0% | +56.7% | |
| Nov 16, 2020 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 12,000 | $65.95 | $791,400.00 | -60.2% | - | - | |
| Jun 5, 2020 | PCRX Pacira Biosciences, Inc. | Director | Sell | 2,100 | $48.70 | $102,270.00 | -24.0% | - | - | |
| Jan 7, 2020 | ACAD Acadia Pharmaceuticals Inc | Director | Sale+OE | 10,000 | $42.19 | $421,900.00 | -100% | - | - |
Page 1Next →